Manulife (Manufacturers Life Insurance)’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
RCM
TGA
O
AVLSA
ES
Manulife (Manufacturers Life Insurance)'s SION Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Sionna Therapeutics (SION) stake by 7.2% in Q1 2026, selling an estimated $190K and leaving 64,458 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1399.
Manulife (Manufacturers Life Insurance) first reported a position in SION in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.87M in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 64,458 shares of Sionna Therapeutics worth $2.58M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 4,966 Sionna Therapeutics shares in Q1 2026, an estimated $190K.
- Sionna Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1399 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 5 quarters since.
- Manulife (Manufacturers Life Insurance)'s Sionna Therapeutics position peaked at $2.87M in Q4 2025.
- 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.